Drug class review on fixed dose combination drug products for the treatment of type 2 diabetes and hyperlipidemia final report
The combination of 2 drug entities in one dosage form is known as a fixed-dose combination product (FDCP). For the treatment of type 2 diabetes, there are 2 products that combine a sulfonylurea with metformin, 2 that combine metformin with a thiazolidinedione, 1 that combines metformin with a Dipept...
Main Author: | |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Portland, Or.
Oregon Health & Science University
c2007, 2007
|
Series: | Drug class reviews
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references